DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,296 | +1.5% | 5,225 | -1.8% | 0.05% | +5.9% |
| Q2 2023 | $1,277 | -6.7% | 5,319 | -2.1% | 0.05% | -13.6% |
| Q1 2023 | $1,369 | -5.1% | 5,432 | 0.0% | 0.06% | -10.6% |
| Q4 2022 | $1,442 | -99.9% | 5,432 | -0.1% | 0.07% | -7.0% |
| Q3 2022 | $1,405,000 | -0.3% | 5,440 | -2.1% | 0.07% | +7.6% |
| Q2 2022 | $1,409,000 | -16.5% | 5,558 | -3.3% | 0.07% | -2.9% |
| Q1 2022 | $1,687,000 | -7.1% | 5,750 | +4.2% | 0.07% | -4.2% |
| Q4 2021 | $1,816,000 | +8.0% | 5,520 | 0.0% | 0.07% | 0.0% |
| Q3 2021 | $1,681,000 | +10.4% | 5,520 | -2.6% | 0.07% | +10.9% |
| Q2 2021 | $1,522,000 | +54.2% | 5,670 | +29.2% | 0.06% | +45.5% |
| Q1 2021 | $987,000 | +6.0% | 4,387 | +4.7% | 0.04% | 0.0% |
| Q4 2020 | $931,000 | +0.5% | 4,192 | -2.5% | 0.04% | -12.0% |
| Q3 2020 | $926,000 | +19.3% | 4,301 | -2.0% | 0.05% | +11.1% |
| Q2 2020 | $776,000 | +23.0% | 4,391 | -3.7% | 0.04% | +2.3% |
| Q1 2020 | $631,000 | -14.3% | 4,558 | -4.9% | 0.04% | +12.8% |
| Q4 2019 | $736,000 | +7.3% | 4,793 | +0.8% | 0.04% | 0.0% |
| Q3 2019 | $686,000 | +0.1% | 4,753 | -0.8% | 0.04% | 0.0% |
| Q2 2019 | $685,000 | -11.3% | 4,791 | -18.0% | 0.04% | -15.2% |
| Q1 2019 | $772,000 | -6.4% | 5,846 | -26.9% | 0.05% | -16.4% |
| Q4 2018 | $825,000 | -8.9% | 8,001 | -4.1% | 0.06% | +5.8% |
| Q3 2018 | $906,000 | +10.1% | 8,341 | 0.0% | 0.05% | +4.0% |
| Q2 2018 | $823,000 | -32.8% | 8,341 | -33.3% | 0.05% | -34.2% |
| Q1 2018 | $1,224,000 | -19.6% | 12,506 | -23.7% | 0.08% | -17.4% |
| Q4 2017 | $1,522,000 | +8.3% | 16,392 | 0.0% | 0.09% | +2.2% |
| Q3 2017 | $1,406,000 | +2.1% | 16,392 | +0.5% | 0.09% | -3.2% |
| Q2 2017 | $1,377,000 | -1.5% | 16,312 | -0.2% | 0.09% | -3.1% |
| Q1 2017 | $1,398,000 | +7.9% | 16,347 | -1.8% | 0.10% | +4.3% |
| Q4 2016 | $1,296,000 | -1.3% | 16,652 | -0.6% | 0.09% | -5.2% |
| Q3 2016 | $1,313,000 | -19.2% | 16,746 | +4.0% | 0.10% | -21.1% |
| Q2 2016 | $1,626,000 | +0.3% | 16,096 | -5.8% | 0.12% | -1.6% |
| Q1 2016 | $1,621,000 | -0.2% | 17,086 | -2.3% | 0.12% | -2.3% |
| Q4 2015 | $1,624,000 | +2.3% | 17,486 | -6.1% | 0.13% | -2.3% |
| Q3 2015 | $1,587,000 | -1.5% | 18,619 | -1.1% | 0.13% | +5.6% |
| Q2 2015 | $1,611,000 | +0.3% | 18,819 | -0.5% | 0.12% | 0.0% |
| Q1 2015 | $1,606,000 | -1.4% | 18,919 | -0.5% | 0.12% | -2.4% |
| Q4 2014 | $1,629,000 | +23.4% | 19,009 | +9.4% | 0.13% | +19.8% |
| Q3 2014 | $1,320,000 | -3.2% | 17,369 | +0.3% | 0.11% | -3.6% |
| Q2 2014 | $1,363,000 | +6.7% | 17,314 | +1.6% | 0.11% | +1.9% |
| Q1 2014 | $1,278,000 | -2.0% | 17,039 | +0.9% | 0.11% | -3.6% |
| Q4 2013 | $1,304,000 | +11.4% | 16,895 | 0.0% | 0.11% | +1.8% |
| Q3 2013 | $1,171,000 | +7.5% | 16,895 | -1.8% | 0.11% | +2.8% |
| Q2 2013 | $1,089,000 | – | 17,206 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |